Comparison between two radiolabeled Nb constructs, [89Zr]Zr-Nb159 (~ 15 kDa) versus [89Zr]Zr-PEG-Nb159 (~ 36 kDa), revealed distinct pharmacokinetic profiles in FAP+ tumor-bearing mice. The gene discussed is FAP; the disease is neoplasm.